Seizure (peds): Difference between revisions

(Text replacement - "* " to "*")
(Text replacement - "w/o" to "with out")
Line 42: Line 42:

===Epileptic Seizures===
===Epileptic Seizures===
*Epilepsy = 2 or more sz w/o acute provocation (fever, trauma)
*Epilepsy = 2 or more sz with out acute provocation (fever, trauma)
*Often due to patient "outgrowing" their dosage
*Often due to patient "outgrowing" their dosage
*Check levels of:
*Check levels of:
Line 63: Line 63:

===Status Epilepticus===
===Status Epilepticus===
*Seizure or recurrent sz lasting >5min w/o regaining consciousness
*Seizure or recurrent sz lasting >5min with out regaining consciousness
**If prolonged postictal state or longer than usual consider nonconvulsive status
**If prolonged postictal state or longer than usual consider nonconvulsive status
***Obtain emergency EEG; if not available trial of anticonvulsants appropriate
***Obtain emergency EEG; if not available trial of anticonvulsants appropriate

Revision as of 09:45, 9 July 2016


  • Consider neuroimaging for new-onset focal seizure
  • Todd paralysis
    • Temporary focal deficit up to 36 hr post-seizure
  • Lateral tongue biting - 100% sp

Seizure Types

Classification is based on the international classification from 1981[1]; More recent terms suggested by the ILAE (International League Against Epilepsy) task Force.[2]

Focal seizures

(Older term: partial seizures)

  • Without impairment in consciousness– (AKA Simple partial seizures)
    • With motor signs (ex. facial twiching or rhythmic ipsilateral extremity movements)
    • With sensory symptoms (ex. tingling or pereiving a certain smell)
    • With autonomic symptoms or signs (ex. tachycardia or diaphoresis)
    • With psychic symptoms (including aura, ex. sense of déjà-vu)
  • With impairment in consciousness - (AKA Complex Partial Seizures--Older terms: temporal lobe or psychomotor seizures)
    • Simple partial onset, followed by impairment of consciousness
    • With impairment of consciousness at onset
    • These seizures may be accompanied by automatism (such as lip smacking and chewing, hand wringing, patting and rubbing)
  • Focal seizures evolving to secondarily generalized seizures
    • Simple partial seizures evolving to generalized seizures
    • Complex partial seizures evolving to generalized seizures
    • Simple partial seizures evolving to complex partial seizures evolving to generalized seizures

Generalized seizures

  • Absence seizures (Older term: petit mal; brief dissociative states without postural changes)
    • Typical absence seizures
    • Atypical absence seizures (last longer and often include more motor involvement)
  • Myoclonic seizure (violent muscle contractions)
  • Clonic seizures (rhythmic jerking)
  • Tonic seizures (stiffening)
  • Tonic–clonic seizures (Older term: grand mal)
  • Atonic seizures (loss of muscle tone -> drop attacks)


  • Sudden Unexpected Death in Epilepsy
  • Generalized tonic-clonic seizure is the major risk factor for SUDEP, and seizure freedom is strongly associated with decreased risk
    • Annual incidence of SUDEP in children is 1 in 4500
    • Incidence in adults is 1 in 1000

Clinical Features

  • Abrupt onset, may be unprovoked
  • Brief duration (typically <2min)
  • AMS
  • Jerking of limbs
  • Postictal drowsiness/confusion (typically lasting <30 minutes)
  • Todd paralysis
  • Lateral tongue biting - 100% specificity
  • Incontinence

Differential Diagnosis

Pediatric seizure


Seizure with a Fever

First-Time Afebrile Seizure

  • If patient returns to baseline no labs/imaging necessarily indicated
    • Consider glucose, chemistry, utox
  • LP only necessary if concern for meningitis
  • EEG should be performed within 24-48hr
  • Neuroimaging
    • Preferred test is outpt MRI
    • Consider emergent imaging for focal deficit, no return to baseline
  • 40% have 2nd sz

Neonatal Seizure

  • Often subtle, focal, poor prognosis
    • Less often have generalized tonic-clonic seizures
      • Findings include lip smacking, eye deviation, staring, ALTE
  • Work-up
    • CBC, chemistry, UA, CSF (including HSV), utox (withdrawal)
    • Consider neuroimaging if concern for abuse, ICH, mass
    • Consider lactate, ammonia if concern for errors of metabolism
  • Treatment
    • Start IV abx (including acyclovir)
    • Consider B6 and folic acid responsive etiologies unresponsive to benzos[5]
      • x2 doses pyridoxal phosphate 10 mg/kg/dose 2 hrs apart
      • If persistent, x2 doses of folinic acid 5 mg 6 hrs apart
      • EEG monitoring during this period is helpful

Epileptic Seizures

  • Epilepsy = 2 or more sz with out acute provocation (fever, trauma)
  • Often due to patient "outgrowing" their dosage
  • Check levels of:
    • Phenytoin, carbamazepine, valproic acid
      • If low consider non-compliance, "outgrowing," vomiting, med interaction
  • Pts with epilepsy may have lower sz threshold with febrile illness
    • Usually can limit ED w/u to fever evaluation

Seizure with VP shunt

  • Consider underlying epilepsy, shunt malfunction, CNS infection
    • If patient has fever seizure more likely secondary to infection than malfunction
      • Consult pediatric neurosurgeon to tap the shunt
  • Imaging
    • Obtain shunt series and head CT or MRI to evaluate for incr ventricular size

Seizure with Trauma

  • "Impact seizures" (sz that occurs w/in minutes of head trauma)
    • Not associated with severe head injuries
  • Sz that occur after this time more likely to represent intracranial injury

Status Epilepticus

  • Seizure or recurrent sz lasting >5min with out regaining consciousness
    • If prolonged postictal state or longer than usual consider nonconvulsive status
      • Obtain emergency EEG; if not available trial of anticonvulsants appropriate
  • Management
    • Glucose, chemistry, CBC, LFT, ?CSF, ?neuroimaging
    • Intubate if e/o apnea and persistent hypoxia
    • If use paralytic EEG monitoring should be arranged


1st Line

Drug[6] Route Dose* Maximum Onset of Action Duration of Action
Lorazepam IV, IO, IN
0.1 mg/kg 4 mg 1–5 min 12–24 h
IM 0.1 mg/kg 4 mg 15–30 min 12–24 h
Diazepam IV, IO 0.1–0.3 mg/kg 10 mg 1–5 min 15–60 min
PR 0.5 mg/kg 20 mg 3–5 min 15–60 min
Midazolam IV, IO 0.1–0.2 mg/kg 4 mg 1–5 min 1–6 h
IM 0.2 mg/kg 10 mg 5–15 min 1–6 h
IN 0.2 mg/kg 10 mg 1–5 min 1–6 h
0.5 mg/kg 10 mg 3–5 min 1–6 h

2nd Line

  • If sz persists for another 5 min after 2 doses of benzos switch to fosphenytoin or phenobarbital
    • Fosphenytoin is usually preferred 2nd line agent 
    • Consider phenobarb over fosphenytoin if febrile illness, <2yr
Drug Route Loading Dose Repeat Dose Maximum IV Infusion
Fosphenytoin IV, IM 15–20 mg/kg PE 5–10 mg/kg PE 30 mg/kg PE 3 mg/kg/min PE
Phenobarbital IV 15–20 mg/kg 5–10 mg/kg 40 mg/kg 1–30 mg/min
Valproic acid IV 20 mg/kg 15–20 mg/kg 40 mg/kg 5 mg/kg/hr
Levetiracetam IV 20–30 mg/kg 3 grams
Pentobarbital IV 5–15 mg/kg 1–2 mg/kg 15 mg/kg 0.5–5.0 mg/kg/hr
Propofol IV 0.5–2.0 mg/kg 0.5–1.0 mg/kg 5 mg/kg 1.5–4.0 mg/kg/hr
Midazolam IV 0.1–0.2 mg/kg 0.1–0.2 mg/kg 10 mg 0.05–0.4 mg/kg/hr

3rd Line

  • Consider Valproic acid 20mg/kg over 1-5min; then infusion of 5mg/kg/hr


  • Defined as <50 mg/dL
  • All seizing patients with hypoglycemia should be treated with 2 mL/kg 25% dextrose


  • Consider as cause of sz, esp if Na <120 mEq/L
  • Goal of therapy is to correct quickly to >120, slowly thereafter
    • In actively seizing patient treatment of choice is 3% NaCl
      • 3% NaCl (513 mEq/1000 mL)
        • Na deficit in total mEq = [(wt in kg)x(130 – serum Na level)x0.6] over 20min OR
      • 3% NaCl: 4-6 mL/kg over 20min
    • If no sz activity but Na <120 start 4-6 mL/kg 3% NaCl or 20 mL/kg of NS over 1hr
      • Check Na level after bolus to see if second bolus is necessary
    • If 3% unavailable start NS 20mL/kg


  • Administer 10% calcium gluconate 0.3 mL/kg over 5-10min


  • Consider Pyridoxine (vitamin B6) 1g per g of INH ingested (in D5W IV over 30 min) [7]
  • Consider Pyridoxine Responsive Seizure Disorder - 100mg/pyridoxine is generally effective [8]


If negative workup

  • EEG and MRI outpt Rx
  • Diastat (diazepam) Rectal Kit
    • 2-5 yrs: 0.5 mg/kg
    • 6-11 yrs: 0.3 mg/kg
    • 12+ yrs: 0.2 mg/kg

See Also

External Links


  1. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22:489.
  2. Epilepsia 2015; 56:1515-1523.
  3. Harden C et al. American Academy of Neurology and the American Epilepsy Society. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors. Neurology April 25, 2017 vol. 88 no. 17 1674-1680.
  4. Baxter P. et al. Pyridoxine‐dependent and pyridoxine‐responsive seizures. Developmental Medicine & Child Neurology 2001, 43: 416–42
  5. Robert Surtees and Nicole Wolf. Treatable neonatal epilepsy. Arch Dis Child. 2007 Aug; 92(8): 659–661.
  6. LaRoche SM, Helmers SL. The New Antiepileptic Drugs: Scientific Review. JAMA. 2004;291:605-614.
  7. Minns AB, Ghafouri N, Clark RF. Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy. Pediatr Emerg Care. 2010; 26(5):380-1.
  8. Pyridoxine dependent seizures a wider clinical spectrum. Archives of Disease in Childhood.1983 (58) 415-418.